Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04591431
Title The Rome Trial From Histology to Target: the Road to Personalize Target Therapy and Immunotherapy (ROME)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Fondazione per la Medicina Personalizzata
Indications

gastrointestinal system cancer

lung non-small cell carcinoma

breast cancer

Advanced Solid Tumor

Therapies

Everolimus

Nivolumab

Itacitinib

Erlotinib

Ponatinib

Pemigatinib

Ipatasertib

Ipilimumab

Cobimetinib

Atezolizumab

Palbociclib

Entrectinib

Vemurafenib

Lapatinib

Trastuzumab

Brigatinib

Alectinib

Ado-trastuzumab emtansine

Pertuzumab

Vismodegib

Age Groups: adult | senior
Covered Countries

Additional content available in CKB BOOST